A 12-member Philadelphia jury handed up a $20 million verdict—including $17.5 million in punitive damages—against Johnson & Johnson subsidiary Ethicon in the third pelvic mesh case to go to trial in the city.

It was also the third multimillion-dollar plaintiff's verdict from Philadelphia's pelvic-mesh mass tort program and the latest in a line of megaverdicts against Johnson & Johnson and its subsidiaries across the country over a variety of products.

The verdict in Engleman v. Ethicon, which also included $2.5 million in compensatory damages, was awarded April 28 in the Philadelphia Court of Common Pleas to a New Jersey woman who alleged she suffered life-altering injuries when the mesh eroded inside of her.